-
Magneto-Piezoelectric Scaffolds for Bone Repair
2026-09-15
Wu et al. developed a dual-responsive, 3D-printed scaffold that combines magnetic biofilm disruption with ultrasound-triggered metabolic reprogramming of Icam1+ macrophages. The study links JAK2-STAT3 activation and MAPK-JNK suppression to enhanced oxidative phosphorylation, pro-reparative immune activity, and healing of infectious bone defects.
-
DSS (MW 35000-45000) in Barrier Repair Studies
2026-09-15
Dextran sulfate sodium salt is more than a colitis trigger: it is a time-resolved tool for separating epithelial injury from mucosal repair. This guide connects DSS model design with the GPR35–KLF5 repair circuit to improve assay interpretation in ulcerative colitis research.
-
LTI6426–Panobinostat in Multiple Myeloma
2026-09-14
The reference study shows that the protein disulfide isomerase inhibitor LTI6426 substantially improves panobinostat activity in multiple myeloma models, including a proteasome inhibitor-resistant setting. Its findings support an endoplasmic-reticulum-stress-based combination strategy that may permit lower panobinostat exposure while identifying ATF3, DDIT3/CHOP, and DNAJB1 as candidate pharmacodynamic biomarkers.
-
Schizophrenia Risk Pathways in Developing Neurons
2026-09-14
Liu et al. show that schizophrenia-associated genetic loci converge on different biological pathways in developing cortical interneurons and glutamatergic neurons. Their cell-type-resolved strategy links interneuron risk genes to PKC hyperactivity and arborization deficits, while glutamatergic-neuron risk genes converge on ion transport and impaired calcium currents.
-
Berberine, Evodiamine, and TRPV1 in GERD
2026-09-13
The reference study identifies a mechanistic connection between bitter taste receptor TAS2R38, TRPV1, MAPK/NF-κB signaling, epithelial barrier disruption, and macrophage polarization in gastroesophageal reflux disease. Its combination of rat and human esophageal epithelial models, gene silencing, calcium-mobilization assays, and pharmacological validation supports berberine plus evodiamine as a pathway-oriented strategy for reducing reflux-associated inflammation.
-
4μ8C (SKU B1874): Reliable ER Stress Assays
2026-09-12
Learn how 4μ8C (SKU B1874) can help researchers separate IRE1α RNase signaling from broader effects on viability, proliferation, and cytotoxicity assays. This scenario-based guide covers assay interpretation, solvent handling, cross-pathway controls, and practical product-selection criteria.
-
DIDS Experimental Workflows for Chloride Research
2026-09-12
DIDS enables concentration-guided studies of chloride transport, TRPV1 behavior, vascular tone, and stress-surviving tumor cells. This workflow-focused guide combines product handling, assay controls, and metastasis-oriented interpretation to help researchers distinguish channel effects from broader cell-stress responses.
-
Cy5-Labeled mRNA for LNP Assay Design
2026-09-11
Cy5-labeled mRNA can separate cellular delivery from protein expression in advanced LNP experiments. This article explains how EZ Cap™ Cy5 EGFP mRNA (5-moUTP) supports mechanistic assay design, carrier comparison, and more defensible interpretation of transfection results.
-
Neticonazole Hydrochloride: Assay Guide
2026-09-11
This scenario-based guide helps researchers use Neticonazole Hydrochloride, SKU C8715, in antifungal, cell-viability, apoptosis, and exploratory exosome workflows. It connects documented solubility, storage, biological activity, and clinical mycology evidence with practical controls for more interpretable experiments.
-
UK-5099 Workflows for Immunometabolism
2026-09-10
UK-5099 (PF-1005023) enables controlled testing of how mitochondrial pyruvate entry shapes cytokine production, respiration, and energy balance. This workflow-focused guide connects standardized whole-blood stimulation with orthogonal metabolic assays, glucose-stimulated insulin secretion, and glucose tolerance studies.
-
Phosphatase Inhibitor Cocktail 1 for Cardiac Signaling
2026-09-10
Phosphatase Inhibitor Cocktail 1 protects phosphorylation-dependent measurements during cardiac tissue and cell lysate preparation, supporting Western blotting, immunoprecipitation, and phosphoproteomic analysis. Its combined activity against alkaline and serine/threonine phosphatases provides broader practical coverage than relying on a single inhibitor, while its DMSO-based format enables straightforward 1X preparation.
-
Methoxy-X04 Workflow for Amyloid Imaging
2026-09-09
Methoxy-X04 combines brain permeability with high-affinity fluorescent labeling for rapid plaque, fibril, and cerebrovascular amyloid readouts. This workflow shows how to use it as a practical endpoint in Alzheimer’s disease research, including exercise-induced extracellular-vesicle studies.
-
(S)-(+)-Dimethindene maleate Protocol Guide
2026-09-09
This guide explains how to use (S)-(+)-Dimethindene maleate as a research antagonist for M2 muscarinic and H1 histamine receptor workflows when concentration-response and selectivity conditions must be established experimentally. It supports controlled in vitro or ex vivo pharmacology studies, but it should not be used for diagnosis, treatment, or as evidence for clinical efficacy.
-
Caffeine Workflows for Cancer and Metabolism
2026-09-08
Build reproducible Caffeine experiments spanning sarcoma cell line inhibition, valproic acid combination studies, and energy-balance research. This guide connects formulation, assay controls, and translational interpretation while keeping caffeine evidence distinct from emerging ALDH2 cardiovascular research.
-
SIRT1/2 Inhibitor IV: Mechanism-to-Assay Guide
2026-09-08
SIRT1/2 Inhibitor IV, also known as cambinol, is a dual SIRT1/SIRT2 tool for connecting deacetylase activity with p53 acetylation, tumor biology, hypoxia, and lactate-regulated signaling. This guide emphasizes causal assay design and the limits of interpreting dual-target pharmacology in cancer and CNS models.